Ildiko ☕️
@IldikoMe
Interested in healthcare, law, patents, pharma, nutrition, microbiome, pediatric IBD & Celiac. Happy to have nuanced discussions.
Delighted to share we are holding the first ever iUSCAN training for pediatric GIs at the ICN Community Conference on September 20, 2025 in Orlando, FL under the leadership of @DrMikeDolinger and the newly established IUS Committee of ICN. We are able to offer this at a very low…
Thanks for sharing @IldikoMe! I’ve indeed seen this interview, and it was truly life-changing for me! I share it with anyone who shows interest in the topic. It was also the turning point when I finally took my bile acid malabsorption seriously. It turned out to be the missing…
Not surprising but good to have confirmation of this. Something suggested in other papers. Ileal CD is a different type of Crohn’s disease. Genetic findings are unique. Biology is probably very different. The question is why?
A bombshell metaanalysis just landed in @AGA_CGH : Advanced therpies work better in colonic #Crohn vs. Ileal dis 😱 aTNFs/aIL23-aIL12/23 were all more effective in the colon, aIntegrin same efficacy in both(?), and JAKi were ONLY EFFECTIVE IN COLON.... cghjournal.org/article/S1542-…
For the FIRST time since any of our family of 5 were diagnosed with #IBD - we are ALL currently in remission. It has taken over 10 yrs and many tough periods. I was not sure we would ever see this day and I could not be more grateful. Now to keep us this way… #TimeForSummerFun
4/ Mucosa-associated 16S rRNA microbiome (neo-TI and colon) revealed: 📈 ↑ Klebsiella in IAU group (q<0.05) Also elevated in patients who later developed POR. 🔬 Suggests microbial role in pathogenesis.
Today I had the pleasure of presenting at a @PANCCO webinar a tool I’ve developed to simplify the calculation and interpretation of intestinal ultrasound indices for Crohn’s Disease and Ulcerative Colitis. After weeks of work, it’s now available — free! 👉 ibduscore.com…
Very cool pictorial. To add: Both Risa and Miri have Fc LALA mutation to reduce effector ADCC/CDC potential. In contrast, Gus is wild type Ab (unmutated, hence binds CD64=FcRI), but still given/4w or/8w. Whether wild type will yield ⬆️AE or better efficacy remains to be seen.
🎯 Extending the Half-Life of mAbs: Why It Matters in IBD In Crohn’s disease and ulcerative colitis, therapeutic monoclonal antibodies often require frequent dosing—which can burden patients and strain healthcare systems. 🧬 Enter Fc engineering: By tweaking the Fc region of…
Intestinal ultrasound training opportunity for both peds and adult GIs!
Only a few more days to apply for the first IBUS Hybrid Module 1 course geared toward Pediatric Gastroenterologists in affiliation with the @NASPGHAN annual meeting in Chicago, Nov 4, 2025! Apply by July 31st! @BowelUltrasound @iUSCAN ibus-group.org/event/workshop…
Amazing work and so much potential here to revolutionize IBD prediction, prevention and care.
Excited to share a milestone published in @NatureMedicine from our decade-long effort to build The Human Phenotype Project, a unique longitudinal cohort with unmatched depth of clinical and multi-omic profiling, enabling truly predictive, personalized medicine. Led together with…
+1 for first line vedo (as always, in the right patient). Even better when combined with diet.
Vedolizumab: a nice option if used in bio-naive #UC patients. Not possible in our setting as short-term costs the only reasoning for some. Thanks for sharing these key data. @Bealoquebea @charlie_lees
Construct Validity of the Toronto IBD Global Endoscopic Reporting Score Compared to Inflammatory Biomarkers After 12-Month Follow-Up @IBDJournals academic.oup.com/ibdjournal/art…
Join us ! Open #Postdoc position in my lab (Paris, France), to work on the Role of the Gut #microbiota in Host Cells Energy Metabolism in Health and #IBD see details here 🔽🔽🔽🔽 euraxess.ec.europa.eu/jobs/361342 please RT
Happy to share our study on #EEN in #CrohnsDisease: ✅Early assessment by week 3 predicts remission at end of therapy ✅Adherence = better outcomes ✅Frequent dietitian review boosts completion rates 💡 Dietetic support is crucial to successful EEN therapy onlinelibrary.wiley.com/doi/10.1002/jg…
First ever ECCO consensus on diet in IBD. Historic moment for clinical application of diet. Dietitian access to all patients for IBD recommended. @Alice_APD @Jess_Fitz_APD @VaioSvolos @KGerasimidis @BonehRotem @LGodny @sarbagili @ProfWhelan @kgikas10 pubmed.ncbi.nlm.nih.gov/40650933/
The US healthcare economy takeover nytimes.com/interactive/20…
@mikedolinger #joellestpierre kicking off IUS train the trainer @ucalgarymed passionately debating is IUS competency based on #'s or skills? @novakkerri 🏆 Best is a combination of skills, proficiency, observed competency and a minimum cut off # IUS. @BowelUltrasound @iUSCAN
Opportunities in collaboration, advocacy, research, and education. YES.
🔵 Interested in Global IBD and future scenarios? Very happy to see our review published in @UEGJournal with IBD Master and good friend @ibdseb 👍
We’re committed to being a stable funder and champion of promising biomedical research. We invite applications for our Innovator Awards from Aug 1-Sept 30. Grants will support individual and collaborative research that advances the understanding of #IBD. krfoundation.org/news/health/ib…
1/3rd of US teens (>8 million kids) have prediabetes gis.cdc.gov/grasp/diabetes…